Encore Medical, Inc. (EMI)

Encore Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Net Income	-1.58	-1.85	-1.39
Depreciation & Amortization	0.01	0.01	0.01
Share-Based Compensation	-	0.7	0.01
Other Operating Activities	1.02	0.68	-0.29
Operating Cash Flow	-0.55	-0.46	-1.66
Capital Expenditures	-0	-	-0.01
Investing Cash Flow	-0	-	-0.01
Share Issuance / Repurchase	-	0.4	-
Debt Issued / Paid	-	-	1.05
Financing Cash Flow	0.52	0.4	1.05
Net Cash Flow	-0.03	-0.06	-0.63
Free Cash Flow	-0.55	-0.46	-1.67
Free Cash Flow Margin	-26.44%	-21.66%	-116.60%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).